1. Signaling Pathways
  2. Cell Cycle/DNA Damage
    Epigenetics
  3. PARP
  4. TNKS2/PARP5B Isoform

TNKS2/PARP5B

 

TNKS2/PARP5B Related Products (21):

Cat. No. Product Name Effect Purity
  • HY-15147
    XAV-939
    Inhibitor 99.91%
    XAV-939 is a Tankyrase inhibitor.
  • HY-12438
    G007-LK
    Inhibitor 99.42%
    G007-LK is a potent and selective inhibitor of TNKS1 and TNKS2, with IC50s of 46 nM and 25 nM, respectively.
  • HY-13990
    NVP-TNKS656
    Inhibitor 99.31%
    NVP-TNKS656 is a highly potent, selective, and orally active TNKS2 inhibitor with IC50 of 6 nM, and is > 300 fold selectivity against PARP1 and PARP2.
  • HY-100225
    ME0328
    Inhibitor 99.87%
    ME0328 is a potent and selective ARTD3/PARP3 inhibitor with an IC50 of 0.89±0.28 μM.
  • HY-16910
    WIKI4
    Inhibitor 99.93%
    WIKI4 is a potent tankyrase inhibitor with an IC50 of 26 nM for TNKS2.
  • HY-148566
    OUL232
    Inhibitor
    OUL232 is a potent inhibitor of mono-ARTs PARP7, PARP10, PARP11, PARP12, PARP14, and PARP15.
  • HY-148753
    PARP10-IN-2
    Inhibitor
    PARP10-IN-2 is a potent mono‐ADP‐ribosyltransferase PARP10 inhibitor with an IC50 of 3.64 μM for human PARP10.
  • HY-W294889
    OUL245
    Inhibitor
    OUL245 is a 7-Hydroxy derivative, and a selectively PARP2 inhibitor (IC50=44 nM).
  • HY-122661
    Mefuparib hydrochloride
    Inhibitor 98.94%
    Mefuparib hydrochloride (MPH) is an orally active, substrate-competitive and selective PARP1/2 inhibitor with IC50s of 3.2 nM and 1.9 nM, respectively.
  • HY-12418
    Stenoparib
    Inhibitor ≥98.0%
    E7449 is a potent PARP1 and PARP2 inhibitor and also inhibits TNKS1 and TNKS2, with IC50s of 2.0, 1.0, ∼50 and ∼50 nM for PARP1, PARP2, TNKS1 and TNKS2, respectively, using 32P-NAD+ as substrate.
  • HY-123892
    RK-287107
    Inhibitor 99.81%
    RK-287107 is a potent and specific tankyrase inhibitor with IC50s of 14.3 and 10.6 nM for tankyrase-1 and tankyrase-2, respectively.
  • HY-19351
    MN-64
    Inhibitor 99.73%
    MN-64 is a potent tankyrase 1 inhibitor, with IC50s of 6 nM, 72 nM, 19.1 μM, and 39.4 μM for TNKS1, TNKS2, ARTD1 and ARTD2, respectively.
  • HY-145267
    OM-153
    Inhibitor 99.59%
    OM-153 is a potent and orally active tankyrase inhibitor with IC50s of 13 nM and 2 nM for tankyrase 1 and tankyrase 2 (TNKS1/2), respectively.
  • HY-U00422
    K-756
    Inhibitor 99.76%
    K-756 is a direct and selective tankyrase (TNKS) inhibitor, which inhibits the ADP-ribosylation activity of TNKS1 and TNKS2 with IC50s of 31 and 36 nM, respectively.
  • HY-121719
    TIQ-A
    Inhibitor 99.65%
    TIQ-A is a potent TNKS (poly-ART, PARP) inhibitor, with an IC50 of 24 nM for TNKS2.
  • HY-147886
    PARP1-IN-11
    Inhibitor 98.58%
    PARP1-IN-11 (compound 49) is a potent PARP1 inhibitor with IC50 value of 0.082 µM.
  • HY-145266
    OM-1700
    Inhibitor
    OM-1700 is a potent tankyrase inhibitor with IC50s of 127 and 14 nM for tankyrase 1 and tankyrase 2, respectively.
  • HY-108516
    TC-E 5001
    Inhibitor
    TC-E 5001 is an inhibitor of Wnt pathway that inhibits tankyrase 1/2 (TNKS1/2) via novel adenosine pocket binding, with Kds of 79 nM and 28 nM, respectively.
  • HY-143338
    ART-IN-1
    Inhibitor
    ART-IN-1 (compound 7) is a selective PARP inhibitor with IC50s of 19, 22, 2.4, >100, 1.1 µM for PARP2, TNKS2, PARP10, PARP14, PARP15, respectively.
  • HY-146336
    PARP1/2/TNKS1/2-IN-1
    Inhibitor
    PARP1/2/TNKS1/2-IN-1 (Compound I-9) is a dual PARP-1, PARP-2, TNKS1 and TNKS2 inhibitor with IC50 values of 0.25 nM, 1.2 nM, 13.5 nM and 4.15 nM against PARP-1, PARP-2, TNKS1 and TNKS2, respectively.